Legend: Boston Convention & Exhibition Center = CC, Westin Boston Waterfront = W, Seaport Boston Hotel = S
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Activity Details
|
Tweet | ||
113 | Mon, 8/4/2014, 8:30 AM - 10:20 AM | CC-257B | |
Go/No-Go: The Practice for Developing Best-in-Class Product from Statistical Perspective — Topic Contributed Papers | |||
Biopharmaceutical Section | |||
Organizer(s): Xuan Liu, AbbVie | |||
Chair(s): Jun Zhao, AbbVie | |||
8:35 AM | Futility Boundary Design Based on Probability of Success Under New Drug Development Paradigm — Yijie Zhou, AbbVie ; Ruji Yao, Merck ; Bo Yang, AbbVie ; Ram Suresh, GlaxoSmithKline | ||
8:55 AM | Evaluation of Program Success for Programs with Multiple Trials in Binary Outcomes — Meihua Wang, Merck ; Frank Liu, Merck ; Jerald Schindler, Merck | ||
9:15 AM | Selection of Development Pathways with Established or Exploratory Biomarkers — Ming-Xiu Hu, Takeda ; Yi Liu, Takeda ; Feng Gao, Takeda | ||
9:35 AM | Go/No Go Criteria Based on a Joint Evaluation of Efficacy and Safety Using a Clinical Utility Index — Theresa Ashton, GlaxoSmithKline ; Ohad Amit, GlaxoSmithKline ; Kert Viele, Berry Consultants | ||
9:55 AM | Discussant: Bo Yang, AbbVie | ||
10:15 AM | Floor Discussion |
2014 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Professional Development program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.